Related Experiment Video

Updated: Jun 21, 2026

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice
08:15

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice

Published on: September 17, 2015

Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients

Olimpia Ortega1, Isabel Rodriguez, Carolina Gracia

  • 1Nephrology Service, Hospital Severo Ochoa, Leganes, Spain. oortega.hsvo@salud.madrid.org

Nephron. Clinical Practice
|July 16, 2009
PubMed

Insights

Strict volume control in hemodialysis patients may prevent increases in cardiac biomarkers. This strategy appears more effective in patients with initially high biomarker levels, potentially reducing them over time.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Hemodialysis patients often have high comorbidity and cardiac issues.
  • Cardiac biomarker levels can progressively increase over time in these patients.

Purpose of the Study:

  • To analyze longitudinal changes in cardiac biomarkers in hemodialysis patients.
  • To test if strict volume control prevents left-ventricular damage and biomarker increases.

Main Methods:

  • A longitudinal cohort study of 46 hemodialysis patients.
  • Implemented strict volume control: salt restriction, extended dialysis, and regular dry weight assessment.
  • Measured N-terminal pro-B-type natriuretic peptide (NT-proBNP), troponin T, and C-reactive protein (CRP) at baseline and 4, 8, 12 months.

Main Results:

  • Dry weight and systolic blood pressure significantly reduced over time (p < 0.01 and p < 0.05).
  • C-reactive protein (CRP) levels decreased (p < 0.05), while NT-proBNP and troponin T remained stable.
  • Patients with high baseline NT-proBNP showed a significant reduction in troponin T (p = 0.02).

Conclusions:

  • Strict volume control may prevent progressive increases in cardiac biomarkers in hemodialysis patients.
  • The strategy shows a greater impact in patients with higher baseline biomarker levels, potentially reducing them during follow-up.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...